Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Kote-Jarai

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|December 10, 1999
BRCA1, BRCA2 and their possible function in DNA damage responseZ Kote-Jarai, R A Eeles
Biochemistry|July 16, 1996
Structural determinants of the uridine-preferring specificity of RNase PL3A M Vicentini, Z Kote-Jarai, J Hofsteenge
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2012
Beyond prostate-specific antigen - future biomarkers for the early detection and management of prostate cancerE Killick, E Bancroft, Z Kote-Jarai, et al.
Human Mutation|March 10, 2001
An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD)S M Edwards, Z Kote-Jarai, R Hamoudi, et al.
Biochimica Et Biophysica Acta|May 29, 1998
Ribonucleases from rat and bovine liver: purification, specificity and structural characterizationW Zhao, Z Kote-Jarai, Y van Santen, et al.
Anticancer Research|September 1, 1996
Molecular mechanisms in the antiproliferative action of taxol and tiazofurinE Olah, B Csokay, N Prajda, et al.
British Journal of Cancer|June 11, 2008
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
Journal of Internal Medicine|February 8, 2012
Genetic variants associated with predisposition to prostate cancer and potential clinical implicationsC L Goh, F R Schumacher, D Easton, et al.
British Journal of Cancer|May 13, 2004
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
British Journal of Cancer|July 5, 2001
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriersL Kadouri, D F Easton, S Edwards, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|December 10, 1999
BRCA1, BRCA2 and their possible function in DNA damage responseZ Kote-Jarai, R A Eeles
Biochemistry|July 16, 1996
Structural determinants of the uridine-preferring specificity of RNase PL3A M Vicentini, Z Kote-Jarai, J Hofsteenge
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2012
Beyond prostate-specific antigen - future biomarkers for the early detection and management of prostate cancerE Killick, E Bancroft, Z Kote-Jarai, et al.
Human Mutation|March 10, 2001
An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD)S M Edwards, Z Kote-Jarai, R Hamoudi, et al.
Biochimica Et Biophysica Acta|May 29, 1998
Ribonucleases from rat and bovine liver: purification, specificity and structural characterizationW Zhao, Z Kote-Jarai, Y van Santen, et al.
Anticancer Research|September 1, 1996
Molecular mechanisms in the antiproliferative action of taxol and tiazofurinE Olah, B Csokay, N Prajda, et al.
British Journal of Cancer|June 11, 2008
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
Journal of Internal Medicine|February 8, 2012
Genetic variants associated with predisposition to prostate cancer and potential clinical implicationsC L Goh, F R Schumacher, D Easton, et al.
British Journal of Cancer|May 13, 2004
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
British Journal of Cancer|July 5, 2001
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriersL Kadouri, D F Easton, S Edwards, et al.
Pageof 4